Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.4999
Delayed Data
As of Aug 03
 -0.0048 / -0.95%
Today’s Change
0.40
Today|||52-Week Range
1.20
-37.51%
Year-to-Date
No recent news for Provectus Biopharmaceuticals Inc.

Today’s Trading

Previous close0.50
Today’s open0.51
Day’s range0.49 - 0.51
Volume176,151
Average volume (3 months)464,226
Market cap$102.7M
Dividend yield--
Data as of 3:53pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+72.73%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
CPIXCumberland Pharmaceu...-0.34-5.46%
SNSSSunesis Pharmaceutic...-0.02-1.79%
PULMPulmatrix Inc-0.19-2.79%
CTRVContraVir Pharmaceut...+0.31+6.46%
Data as of 3:59pm ET, 08/03/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$10.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
H. Craig Dees
President &
Director
Timothy C. Scott
Corporate headquarters
Knoxville, Tennessee

Forecasts